日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
10/01/2025 | C-Bridge Healthcare Fund GP IV, L.P. | 1201(L) | -6,840,000(L) | 45,682,482(L) | 13.99 | |
10/01/2025 | C-Bridge Healthcare Fund GP II, L.P. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | |
10/01/2025 | C-Bridge Healthcare Fund II, L.P. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | |
10/01/2025 | TF Capital IV Ltd. | 1201(L) | -6,840,000(L) | 45,682,482(L) | 13.99 | |
10/01/2025 | 傅唯 | 1201(L) | -17,100,000(L) | 111,793,427(L) | 34.24 | |
10/01/2025 | C-Bridge Capital GP, Ltd. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | |
10/01/2025 | C-Bridge Capital GP IV, Ltd. | 1201(L) | -6,840,000(L) | 45,682,482(L) | 13.99 | |
10/01/2025 | Nova Aqua Limited | 1201(L) | -17,100,000(L) | 111,793,427(L) | 34.24 | |
10/01/2025 | TF Capital II Ltd. | 1201(L) | -10,260,000(L) | 42,517,778(L) | 13.02 | |
10/01/2025 | C-Bridge Investment Everest Limited | 1201(L) | -9,532,000(L) | 40,468,000(L) | 12.39 | |
10/01/2025 | C-Bridge Healthcare Fund IV, L.P. | 1201(L) | -6,840,000(L) | 45,682,482(L) | 13.99 | |
07/11/2024 | 傅唯 | 1213(L) | -372,450(L) | 128,893,427(L) | 39.55 | |
07/11/2024 | Everest Management Holding Co., Ltd. | 1213(L) | -372,450(L) | 21,683,167(L) | 6.65 | |
05/04/2024 | 罗永庆 | 11031(L) | +2,139,255(L) | 10,459,078(L) | 3.23 | |
05/04/2024 | Woo Ian Ying | 11031(L) | +1,069,628(L) | 3,113,270(L) | 0.96 | |
12/03/2024 | Nova Aqua Limited | 1201(L) | -1,468,000(L) | HKD28.119(L) | 129,265,877(L) | 39.93 |
12/03/2024 | 傅唯 | 1201(L) | -1,468,000(L) | HKD28.119(L) | 129,265,877(L) | 39.93 |
1 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 13/01/2025 18:00 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |